lead position
Sponsored content
Sponsored by
Chang Tsi & Partners
Ryan (Liangrui) Xu of Chang Tsi & Partners summarises key examination hurdles, landmark cases, and strategic opportunities for patent applicants using parameter-defined claims in China
June 4, 2026
Features list
-
Lawyers at Carpmaels & Ransford explain how the healthcare sector has not simply participated in the UPC’s early years, but actively shaped it -
Barry Greenbaum, partner at Olshan Frome Wolosky, explains how in-house teams can update their approach to brand development, and where AI can add value
-
Nick Redfearn and Khanh Nguyen of Rouse discuss Vietnam’s latest identification in the 2026 Special 301 Report and how the country is taking genuine steps to meet US expectations
-
Attorneys at Gibson Dunn share why plaintiffs’ growing reliance on DMCA anti-circumvention claims in AI scraping cases exposes a critical vulnerability
-
The move marks the latest step in Temu’s push to protect brands’ intellectual property by collaborating with industry groups and enforcement agencies. Managing IP learns about a rapidly scaling strategy and two success stories
-
Lawyers at A&O Shearman analyse developments regarding UPC’s long-arm jurisdiction, including its scope and jurisdictional limits
Local Insights
Sponsored by
Licks Attorneys
Eduardo Hallak, Rafaella Oliveira, and Laís Souza of Licks Attorneys explain how the provision operates in practice, highlighting evidential hurdles and best practices for patent applicants
Sponsored by
Liu, Shen & Associates
Chunyu Cui and Ziqing Wu of Liu, Shen & Associates say recent trends in China’s intellectual property courts indicate alignment with international standards and send a clear signal to the global market
Sponsored by
Wanhuida Intellectual Property
Revised examination guidelines and evolving technology have driven a surge in smart medicine patent filings and grants. Jie Zhao of Wanhuida Intellectual Property examines several examples of significance for foreign applicants
Sponsored by
Berken IP
Emilio Berkenwald of Berken IP says that although the move potentially eases prosecution, several issues – particularly concerning second medical use claims – remain
Sponsored by
Inspicos
Nils Byg Jørgensen of Inspicos says a recent EPO decision addresses the extent to which the description and drawings shall be consulted when interpreting claims under European Patent Convention provisions other than patentability
Sponsored by
Gün + Partners
A Turkish case highlights the importance of Article 138(3) when patent claims are amended during an invalidation action, say Selin Sinem Erciyas, Aysel Korkmaz Yatkın, and Bengü Şen Gürakan of Gün + Partners
Sponsored by
Hechanova Group
The proposal clarifies what constitutes proof of commercial use of a trademark in the country, report Editha R Hechanova, Noemi P Rivera, and Lance Freidrich Phillipe M Asido of Hechanova Group
Sponsored by
Inspicos
Jakob Pade Frederiksen of Inspicos provides a status update on the pending case in the lead-up to oral proceedings before the EPO Enlarged Board of Appeal on May 8 2026
Sponsored by
Hanol IP & Law
Min Son of Hanol IP & Law analyses a Supreme Court ruling clarifying that prosecution history in a parent application can later limit the scope of divisional patent claims
Sponsored by
INLEX
Igor Charles and Fatima Chirazi of INLEX report on the rejection of Decathlon’s design, unfair competition, and parasitism claims over snorkelling masks, confirming a narrow scope of protection where design freedom is constrained